|McElrath: Innate to Adaptive Immunity
|Protein & peptide vaccines
|Study Start Date:
|Study Made Public:
Evaluating the impact in nonhuman primates of using nano particle formulated TLR 4 and 7 agonists for enhancing humoral immunity against HIV specific envelope protein immunogens - a study conducted by the Pulandran laboratory
CAVD 355 (CAVIMC-045) is a non-human primate study of protein and adjuvant regimens.
Sign in to see full information about this study and to download study data.